JP2012523235A - Pdhおよびfdh酵素を発現する遺伝学的に安定なプラスミド - Google Patents

Pdhおよびfdh酵素を発現する遺伝学的に安定なプラスミド Download PDF

Info

Publication number
JP2012523235A
JP2012523235A JP2012504868A JP2012504868A JP2012523235A JP 2012523235 A JP2012523235 A JP 2012523235A JP 2012504868 A JP2012504868 A JP 2012504868A JP 2012504868 A JP2012504868 A JP 2012504868A JP 2012523235 A JP2012523235 A JP 2012523235A
Authority
JP
Japan
Prior art keywords
seq
nucleic acid
sequence
polypeptide
fdh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012504868A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012523235A5 (https=
Inventor
ジョナサン・バッシュ
トーマス・フランセスキーニ
スオ・ウィン・リュー
シュ−ジェン・チャン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of JP2012523235A publication Critical patent/JP2012523235A/ja
Publication of JP2012523235A5 publication Critical patent/JP2012523235A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0008Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • C12N15/68Stabilisation of the vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0016Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1)
    • C12N9/0018Phenylalanine dehydrogenase (1.4.1.20)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
JP2012504868A 2009-04-08 2010-04-08 Pdhおよびfdh酵素を発現する遺伝学的に安定なプラスミド Pending JP2012523235A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16767609P 2009-04-08 2009-04-08
US61/167,676 2009-04-08
PCT/US2010/030404 WO2010118240A1 (en) 2009-04-08 2010-04-08 A genetically stable plasmid expressing pdh and fdh enzymes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014041887A Division JP2014128281A (ja) 2009-04-08 2014-03-04 Pdhおよびfdh酵素を発現する遺伝学的に安定なプラスミド

Publications (2)

Publication Number Publication Date
JP2012523235A true JP2012523235A (ja) 2012-10-04
JP2012523235A5 JP2012523235A5 (https=) 2013-11-07

Family

ID=42200623

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012504868A Pending JP2012523235A (ja) 2009-04-08 2010-04-08 Pdhおよびfdh酵素を発現する遺伝学的に安定なプラスミド
JP2014041887A Pending JP2014128281A (ja) 2009-04-08 2014-03-04 Pdhおよびfdh酵素を発現する遺伝学的に安定なプラスミド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014041887A Pending JP2014128281A (ja) 2009-04-08 2014-03-04 Pdhおよびfdh酵素を発現する遺伝学的に安定なプラスミド

Country Status (7)

Country Link
US (1) US8158394B2 (https=)
EP (1) EP2417260A1 (https=)
JP (2) JP2012523235A (https=)
KR (1) KR101292379B1 (https=)
CN (1) CN102459610B (https=)
SG (1) SG175054A1 (https=)
WO (1) WO2010118240A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018086012A (ja) * 2013-02-28 2018-06-07 ティーウィノット テクノロジーズ リミテッド カンナビノイドの生合成
US10633681B2 (en) 2014-08-25 2020-04-28 Teewinot Technologies Limited Apparatus and methods for biosynthetic production of cannabinoids

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103965065B (zh) * 2013-02-01 2016-02-17 上海现代制药股份有限公司 沙格列汀中间体、其盐、其制备方法及其用途
CN103555683B (zh) * 2013-11-19 2015-11-18 南京博优康远生物医药科技有限公司 一种沙格列汀手性中间体的合成方法
WO2015087262A1 (en) 2013-12-11 2015-06-18 Ranbaxy Laboratories Limited Process for the preparation of saxagliptin and its intermediates
CN103951588B (zh) * 2014-04-30 2016-10-05 淮海工学院 一种合成沙格列汀中间体n-叔丁氧羰基-3-羟基-1-金刚烷基-d-甘氨酸的方法
CN108795893B (zh) * 2018-06-27 2021-10-08 凯莱英医药集团(天津)股份有限公司 一种氨基酸脱氢酶突变体及其制备方法和应用
CN112391363B (zh) * 2021-01-21 2021-04-06 凯莱英生命科学技术(天津)有限公司 氨基酸脱氢酶突变体及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050090539A1 (en) * 2002-12-09 2005-04-28 Vu Truc C. Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
WO2005106011A2 (en) * 2004-04-14 2005-11-10 Bristol-Myers Squibb Company Process for preparing dipeptidyl iv inhibitors and intermediates therefor
EP1918375A1 (en) * 2005-08-02 2008-05-07 Kaneka Corporation D-amino acid oxidase, and method for production of l-amino acid, 2-oxo acid or cyclic imine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6068991A (en) * 1997-12-16 2000-05-30 Bristol-Myers Squibb Company High expression Escherichia coli expression vector
US6395767B2 (en) * 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
US7087418B2 (en) * 2001-12-19 2006-08-08 Bristol-Myers Squibb Company Pichia pastoris formate dehydrogenase and uses therefor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050090539A1 (en) * 2002-12-09 2005-04-28 Vu Truc C. Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
WO2005106011A2 (en) * 2004-04-14 2005-11-10 Bristol-Myers Squibb Company Process for preparing dipeptidyl iv inhibitors and intermediates therefor
EP1918375A1 (en) * 2005-08-02 2008-05-07 Kaneka Corporation D-amino acid oxidase, and method for production of l-amino acid, 2-oxo acid or cyclic imine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN7013001696; Galkin A et al: 'Synthesis of Optically Active Amino Acids from alpha-Keto Acids and Escherichia coli Cells Expressin' Applied and Environmental Microbiology Vol.63, No.12,, 1997, p.4651-4656 *
JPN7013001698; Kimura S et al: J. Biochem. Vol.137, No.4, 2005, p.523-533 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018086012A (ja) * 2013-02-28 2018-06-07 ティーウィノット テクノロジーズ リミテッド カンナビノイドの生合成
US10472652B2 (en) 2013-02-28 2019-11-12 Teewinot Technologies Limited Chemical engineering processes and apparatus for the synthesis of compounds
US10633681B2 (en) 2014-08-25 2020-04-28 Teewinot Technologies Limited Apparatus and methods for biosynthetic production of cannabinoids

Also Published As

Publication number Publication date
KR20110135990A (ko) 2011-12-20
KR101292379B1 (ko) 2013-08-09
EP2417260A1 (en) 2012-02-15
US20100261236A1 (en) 2010-10-14
JP2014128281A (ja) 2014-07-10
CN102459610B (zh) 2014-12-17
CN102459610A (zh) 2012-05-16
US8158394B2 (en) 2012-04-17
WO2010118240A1 (en) 2010-10-14
SG175054A1 (en) 2011-11-28

Similar Documents

Publication Publication Date Title
JP2014128281A (ja) Pdhおよびfdh酵素を発現する遺伝学的に安定なプラスミド
FR2730495A1 (fr) Derive de proinsuline et procede pour la production d'insuline humaine
CN1681836A (zh) 递送治疗或诊断试剂的导向蛋白质
CN1597697A (zh) 一种人的甲状旁腺素1-34肽相关肽-Pro-Pro-[Arg11]]hPTH(1-34)-Pro-Pro
US6444202B1 (en) Processed polypeptides with IL-16 activity, processes for their production and their use
JP3251592B2 (ja) Il―16活性を有するプロセスされたポリペプチド、それらの製法、及びそれらの使用
JPH03259084A (ja) トロンビン結合性物質の製造法
CN1082091C (zh) 重组人肿瘤坏死因子及制备方法
RU2812047C1 (ru) Вариант интерферона-бета человека с двойной мутацией и способ улучшения стабильности варианта интерферона-бета человека
CN1220701C (zh) 重组人外周淋巴组织趋化性细胞因子及其制备方法和用途
CN1406956A (zh) 一种多肽-外源凝集素蛋白-21.45和编码这种多肽的多核苷酸
CN1465597A (zh) 含可溶性肿瘤坏死因子II型受体和白介素I受体拮抗剂IL1Ra的融合蛋白,其制备方法,及其药物组合物
CN1301859A (zh) 一种新的多肽——人SpaseI酶13和编码这种多肽的多核苷酸
CN1406977A (zh) 一种多肽-p40蛋白-27.06和编码这种多肽的多核苷酸
CN1301752A (zh) 一种新的多肽——plp蛋白10和编码这种多肽的多核苷酸
CN1406978A (zh) 一种多肽-人顶端内体糖蛋白-33.33和编码这种多肽的多核苷酸
CN1300746A (zh) 一种新的多肽-核糖体s7蛋白9和编码这种多肽的多核苷酸
CN1406951A (zh) 一种多肽-人含3-磷酸莽草1-羧基乙烯转移酶特征性序列片段的蛋白-10.45和编码这种多肽的多核苷酸
CN1301770A (zh) 一种新的多肽——人fkbp蛋白11和编码这种多肽的多核苷酸
CN1425765A (zh) 一种多肽——蝶呤钼氧化还原酶-8.91和编码这种多肽的多核苷酸
CN1407095A (zh) 一种多肽——果糖-1,6-二磷酸酶-16.61和编码这种多肽的多核苷酸
JP2000262293A (ja) 活性化蛋白質の製造法
CN1300825A (zh) 一种新的多肽-短链脱氢酶/还原酶蛋白家族27和编码这种多肽的多核苷酸
CN1355215A (zh) 一种新的多肽——人核糖体蛋白 l23-62.48和编码这种多肽的多核苷酸
CN1406985A (zh) 一种多肽-细胞色素蛋白-10.12和编码这种多肽的多核苷酸

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130514

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130813

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130820

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20130913

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20131105

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140304

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20140422

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20140520

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20140704